IGC Pharma Inc (IGC) volume exceeds 1.39 million: A new investment opportunity for investors

Sana Meer

On Friday, IGC Pharma Inc (AMEX: IGC) opened higher 6.04% from the last session, before settling in for the closing price of $0.33. Price fluctuations for IGC have ranged from $0.25 to $0.50 over the past 52 weeks.

During the last 5-year period, the sales growth of Healthcare Sector giant was 12.85%. Company’s average yearly earnings per share was noted 11.11% at the time writing. With a float of $71.51 million, this company’s outstanding shares have now reached $91.96 million.

IGC Pharma Inc (IGC) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of IGC Pharma Inc is 23.22%, while institutional ownership is 5.86%.

IGC Pharma Inc (IGC) Recent Fiscal highlights

If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.02 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.03) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 11.11% per share during the next fiscal year.

IGC Pharma Inc (AMEX: IGC) Trading Performance Indicators

Check out the current performance indicators for IGC Pharma Inc (IGC). In the past quarter, the stock posted a quick ratio of 0.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 29.09.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.08, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach -0.09 in one year’s time.

Technical Analysis of IGC Pharma Inc (IGC)

Looking closely at IGC Pharma Inc (AMEX: IGC), its last 5-days average volume was 0.95 million, which is a drop from its year-to-date volume of 1.13 million. As of the previous 9 days, the stock’s Stochastic %D was 74.63%.

During the past 100 days, IGC Pharma Inc’s (IGC) raw stochastic average was set at 29.73%, which indicates a significant decrease from 86.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0215 in the past 14 days, which was lower than the 0.0247 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.3658, while its 200-day Moving Average is $0.3442. However, in the short run, IGC Pharma Inc’s stock first resistance to watch stands at $0.3585. Second resistance stands at $0.3692. The third major resistance level sits at $0.3806. If the price goes on to break the first support level at $0.3364, it is likely to go to the next support level at $0.3250. Now, if the price goes above the second support level, the third support stands at $0.3143.

IGC Pharma Inc (AMEX: IGC) Key Stats

There are currently 92,868K shares outstanding in the company with a market cap of 32.29 million. Presently, the company’s annual sales total 1,270 K according to its annual income of -7,120 K. Last quarter, the company’s sales amounted to 190 K and its income totaled -1,820 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.